Deep MedChem is a company headquartered in Czechia.
Deep MedChem develops AI-powered software products for accelerating early-stage drug discovery by enabling fast virtual screening, molecular similarity search, and multi-property optimization across ultra-large chemical libraries.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.